PGNY

Progyny Inc.

Price

$31.93

return (12m)

45.14%

p/e

37.63

p/bv

5.80

DIVIDEND YIELD

0.00%

PGNY price

Progyny

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PGNY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

22.43%

3 months

77.19%

1 year

45.14%

2 years

14.90%

5 years

-43.80%

10 years

0.00%

Fundamentals PGNY

Valuation

P/E

37.63

Sector -2.36

Industry 0.98

P/BV

5.80

Sector 2.16

Industry 2.53

P/Revenue (PSR)

1.97

Sector 2.00

Industry 0.76

P/EBITDA

25.01

Sector -0.13

Industry 1.08

P/EBIT

26.39

Sector -2.10

Industry 3.17

P/Total Assets

3.65

Sector 1.17

Industry 0.93

EPS

0.84

Sector -0.93

Industry -0.57

BVPS

5.42

Sector 3.88

Industry 5.17

Efficiency

Gross Margin

24.11%

Sector 44.07%

Industry 30.88%

Operating Margin

7.46%

Sector -25.88%

Industry -7.64%

Net Profit Margins

5.23%

Sector -30.34%

Industry -16.97%

Profitability

ROE

15.40%

Sector -34.57%

Industry -29.67%

ROA

9.69%

Sector -28.64%

Industry -15.42%

ROIC

37.59%

Sector -441.27%

Industry -111.79%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Debt

Equity/Assets

0.63

Sector 0.43

Industry 0.26

Liabilities/Assets

0.37

Sector 0.46

Industry 0.48

Growth

5Y Revenue CAGR

20.90%

Sector -

Industry -

5Y Earnings CAGR

0.57%

Sector -

Industry -

FAIR VALUE OF Progyny ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$31.93

Fair Value

$10.12

Upside Return potential.

-68.30%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals PGNY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
PGNY	37.63	5.80	15.40%	0.00%	$2.55 B	5.23%
CI	11.58	1.78	15.39%	2.16%	$75.20 B	2.34%
UHS	6.06	1.21	20.00%	0.53%	$9.22 B	8.56%
DGX	22.66	3.00	13.22%	1.55%	$23.20 B	9.08%
STRRP	8.16	2.56	31.31%	9.43%	$163.57 M	25.96%
ENSG	27.54	4.22	15.33%	0.15%	$10.01 B	6.89%
CRVL	28.24	7.90	27.99%	0.00%	$3.12 B	11.51%
JYNT	38.39	8.03	20.92%	0.00%	$124.39 M	5.72%
OPCH	16.48	2.51	15.26%	0.00%	$3.40 B	3.64%
MGLN	8.00	1.53	19.13%	0.00%	$2.42 B	6.38%
VAR	58.58	7.26	12.40%	0.00%	$16.26 B	5.85%
PNTG	48.21	3.75	7.79%	0.00%	$1.46 B	2.96%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PGNY Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Progyny

Progyny Inc.

Average Investor10 user rating

4.0 (0 people)

United States

18 years

Founded: 2008

2019

Time since IPO - 7 years

180

Employees

Progyny Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.55 billion, with shareholders equity totaling $439.34 million.

The company employs approximately 180 people and operates in the Health sector, within the Health Establishments industry.

Over the past 12 months, Progyny Inc. reported $1.29 billion in revenue, generating net income of $67.68 million.

Key financial metrics include a P/E ratio of 37.63, a price-to-book (P/B) ratio of 5.80, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PGNY.

Market cap

$2.55 billion

Net worth

$439.34 million

$439,340,000.00

Assets

$698.34 million

$698,340,000.00

Total Shares Outstanding

81.00 million

81,000,000

Average Daily Trading Volume

$1.55 million

$1,552,538.00

Sector

Health

Industry

Health Establishments

PGNY

PGNY revenue and profits

Financial Results PGNY

DRAG THE FRAME TO SEE MORE DATA

PGNY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$109.45 85,17% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$287.16 --0,45% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$67.22 145,04% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$407.13 85,54% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$43.80 --5,01% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$1,163.75 51,17% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$371.79 2,66% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$154.86 38,31% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56